Integrated HPV Screening Wins FICCI Healthcare Excellence Award
An integrated cervical‑cancer screening program for HIV‑positive women at Gujarat Cancer Research Institute has been recognised with the prestigious FICCI Healthcare Excellence Award 2026. The programme, launched in March of the previous year, screened 1,542 women through HPV DNA testing, uncovering a 20.69 % infection rate – a figure dramatically higher than the 4.8‑5.2 % seen in the broader Gujarat population.
Subsequent colposcopic assessments of 150 participants uncovered 94 cases of cervical intra‑epithelial neoplasia (CIN 1: 63, CIN 2: 30, CIN 3: 1) and one early‑stage cervical cancer, highlighting the critical value of early detection. The award acknowledges the seamless incorporation of cancer prevention into routine HIV care, setting a benchmark for patient‑centred service delivery.
State health authorities, in partnership with the Gujarat Cancer Society, plan to scale the model to additional antiretroviral therapy centres across the state, reinforcing preventive health strategies and expanding access to life‑saving early‑diagnosis services.
